Please complete the inquiry form below. One of our staff will contact you within 1 business day
If you or someone you know struggles with rheumatoid arthritis, you’re likely searching for the newest treatment options to manage this chronic condition. For unknown causes, more women get RA than men, and the condition usually develops around middle age. For some, having a family member with RA increases the odds of developing RA later in life. Genetic screening is available to test for hereditary autoimmune diseases. In the last decade, there have been significant advancements in stem cell therapy for rheumatoid arthritis. This groundbreaking treatment has already had a substantial impact on patients suffering from this debilitating chronic disease [1].
In healthy people, the immune system helps to fight invaders, such as viruses and bacteria. With autoimmune diseases like RA, the immune system mistakes their cells as foreign invaders and then releases inflammatory target chemicals to attack their cells. Tn RA attacks the synovium tissue lining around joints, which generally helps produce a fluid that keeps our joints moving smoothly. Over time, the chronically inflamed synovium gets slightly thicker, making the joint area feel painful, red, swollen, and tender. For most, moving those joints becomes difficult [2].
Rheumatoid arthritis (RA) is a common autoimmune disease that causes joint inflammation, leading to pain, swelling, stiffness, and damage. Over time, RA can also affect other organs, leading to various complications. Scientists aren’t exactly sure why some people develop RA. Some research suggests that these individuals may have specific genes that can be activated or triggered by the environment. Bacterial and viral exposure, as well as physical and emotional stress, are external factors that can trigger an autoimmune attack.
Current treatments for rheumatoid arthritis primarily focus on managing symptoms and slowing disease progression. These treatments can include:
Although these treatments can provide some relief, they often come with side effects and may not be effective for everyone. This has led researchers to explore alternative treatment options, such as stem cell therapy for rheumatoid arthritis and for treating Complex Regional Pain Syndrome (CRPS) and other orthopedic joint degeneration ( sports injuries ) in the shoulders, hips, knees, lower back, neck, and spinal cord.
The integrity of your cartilage could slowly wear down, leading to mild to severe daily pain. Osteoarthritis may also affect the hips, knees, spine, and, most notably, the finger joints of your hands. Some people encounter extreme stiffness and pain, and in severe cases, the degenerative joint condition of rheumatoid arthritis can easily result in severe deformities in the affected locations. Learn more about tissue engineering and the basics of stem cell therapies.
RA, or Rheumatoid arthritis, is an orthopedic disease generally occurring in men and women over 40. RA is a long-term degenerative ailment that has significant effects on the joint tissues in the hands, feet, and arms. People dealing with rheumatoid arthritis may typically live with the disease for years without even knowing they have it. Stem cell research has shown that as RA progresses, the severe destruction of your joints will undoubtedly get considerably worse. Learn more about the rheumatoid arthritis diet.
The Regeneration Center protocol for treating rheumatoid arthritis, Hashimoto’s Disease, spinal arthritis, connective tissue disease, spinal stenosis, inclusion body myositis, Ocular Myasthenia gravis MG, osteoporosis and osteoarthritis based on evidence-based research allows for higher success rates, higher cell viability and longer-term improvements and pain management. Our unique MSC+ stem cell therapy takes a natural regenerative approach to symptom relief. It uses enhanced Mesenchymal cells (expanded) with paracrine cell signaling growth factors & chondrocyte implantation to rapidly and successfully fix the impaired cells in your body [3].
Stem cells are unique cells in the body that can self-renew and differentiate into specialized cell types. This exceptional property makes them an attractive option for regenerative medicine and treating various diseases, including rheumatoid arthritis, lupus, Sjogren’s syndrome, Type 1 diabetes, T2D, kidney disease, IBD Crohn’s Disease, pancreatitis, ALS, Alzheimer’s, Parkinson’s, strokes, multiple sclerosis, and cystic fibrosis.
Several types of stem cells have been used in clinical trials of stem cells for rheumatoid arthritis:
The results of several clinical studies have shown that Isolated MSC stem cell therapy did not cause any adverse effects for patients and resulted in clinically verifiable improvements in the following areas:
UC-MSC+ stem cells have gained significant attention in recent years due to their anti-inflammatory, cell signaling, and immunomodulatory properties, making them a promising option for treating rheumatoid arthritis. The Regeneration center protocol for RA uses proprietary methods that enable a 25X increase in the immunomodulatory effects of Isolated MSC Stem cells for RA, employing a combination of tissue-specific growth factors, pro-inflammatory cytokine priming, autophagy, and hypoxia over a 2-week protocol [5].
Polymyalgia rheumatica is often misunderstood, leading to unnecessary pain and suffering. PMR is a debilitating condition that causes muscle pain and stiffness, mainly in the shoulders and hips of those over 50. Effective management is essential to prevent long-term disability and improve quality of life. Recognizing the early symptoms and detecting PMR early can prevent worsening. Many people mistake early signs, like morning stiffness, for normal aging, but It’s crucial to recognize these symptoms early and consult a healthcare provider for treatment.
Getting an accurate diagnosis or misdiagnosis is common in PMR cases, leading to delayed or inappropriate treatments. Diagnostic tests like ESR and CRP can help confirm PMR, differentiating it from other conditions with similar symptoms, like rheumatoid arthritis or fibromyalgia. The standard treatment for PMR is corticosteroids, but dosing needs to be individualized. Too high a dose increases side effects, while too low a dose may not effectively control symptoms. Incorporated physical therapy can help maintain muscle strength and flexibility, preventing long-term stiffness, but many overlook this and rely solely on medications. Patients diagnosed should be monitored for complications, as PMR is associated with conditions like heart failure and giant cell arteritis, which require immediate attention. Regular follow-ups and continuous monitoring for symptoms like vision changes or headaches can help prevent serious complications.
Stem cell therapy offers a promising alternative for managing Polymyalgia Rheumatica (PMR). Current treatments for PMR, like corticosteroids, can lead to significant side effects and are not always effective in the long term. Patients need to understand the potential and limitations of Stem Cell Therapy. Stem cells have unique regenerative properties that modulate the immune system and reduce inflammation. This makes them suitable for conditions like PMR, where inflammation is a primary concern. Stem cell research shows that mesenchymal stem cells (MSCs) can effectively reduce inflammation in various autoimmune diseases.
A frequent mistake patients make is assuming stem cell therapy is a last resort. However, integrating it earlier in the treatment plan can reduce long-term reliance on steroids. Patients should consult specialists who understand conventional and emerging therapies to make informed decisions.
Choosing the right stem cell sources, types, and quantities is crucial because not all stem cells are created equal. MSCs derived from bone marrow or adipose tissue can help temporarily; however, umbilical cord tissue (UC-MSC) cells have shown the most promise in treating inflammatory conditions like PMR. Choosing the right stem cell source is critical to maximizing therapeutic benefits. Depending on scale and severity, the Regeneration Center might recommend combining therapies to achieve optimal results. Combining stem cell therapy with conventional treatments can sometimes enhance efficacy and minimize side effects. A multidisciplinary approach involving rheumatologists and regenerative medicine experts can offer the best outcomes. While still in its early stages, stem cell therapy will revolutionize PMR management, providing hope for those seeking alternatives to traditional treatments.
Stem cell treatment for rheumatoid arthritis primarily focuses on using isolated and expanded UC-MSCs, along with cell-specific growth factors, to target inflammation and promote tissue repair. The process generally involves:
Once inside the body, the isolated MSC cells secrete growth factors that help to:
Stem cell therapy for rheumatoid arthritis has the potential to offer a more comprehensive solution for patients with this chronic condition by addressing both inflammation and joint damage.
While stem cell therapy holds great promise for the treatment of rheumatoid arthritis, several challenges and considerations must be addressed and understood:
Stem cell treatment for rheumatoid arthritis represents a promising new treatment option that will revolutionize the management of this chronic and debilitating disease. Although we are still in the early stages of stem cell science, the results are encouraging, and we will only continue to get better results over time.
UC-MSC+ Stem Cell treatment for rheumatoid arthritis will require 10-14 days. Due to the varying severity, our medical team must evaluate all potential candidates to establish a current baseline and treatment recommendations. Upon completion of the medical evaluation, a detailed treatment plan will be provided that includes the specifics, such as the exact number of nights required, as well as the total medical-related costs. To begin the evaluation process for our multi-stage stem cell treatment for rheumatoid arthritis, please prepare your recent medical records, including radiology scans and blood test results, and contact us today.
[1] ^Munchey R, Pongmesa T. Health-Related Quality of Life and Functional Ability of Patients with Rheumatoid Arthritis: A Study from a Tertiary Care Hospital in Thailand. Value Health Reg Issues. 2018 May;15:76-81. doi: 10.1016/j.vhri.2017.08.012. Epub 2017 Oct 16. PMID: 29474183.
[2] ^Lau CS, Chia F, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, Li Z, Lichauco JJ, Louthrenoo W, Luo SF, Nash P, Ng CT, Park SH, Suryana BP, Suwannalai P, Wijaya LK, Yamamoto K, Yang Y, Yeap SS; Asia Pacific League of Associations for Rheumatology in Thailand. APLAR rheumatoid arthritis treatment recommendations. Int J Rheum Dis. 2015 Sep;18(7):685-713. doi: 10.1111/1756-185X.12754. Erratum in: Int J Rheum Dis. 2015 Nov;18(8):917. PMID: 26334449.
[3] ^Liu H, Li R, Liu T, Yang L, Yin G, Xie Q. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis. Front Immunol. 2020 Aug 20;11:1912. doi: 10.3389/fimmu.2020.01912. PMID: 32973792; PMCID: PMC7468450.
[4] ^Sarsenova M, Issabekova A, Abisheva S, Rutskaya-Moroshan K, Ogay V, Saparov A. Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis. Int J Mol Sci. 2021 Oct 27;22(21):11592. doi: 10.3390/ijms222111592. PMID: 34769021; PMCID: PMC8584240.
[5] ^ Wang L, Huang S, Li S, Li M, Shi J, Bai W, Wang Q, Zheng L, Liu Y. Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study. Thailand Ther. 2019 Dec 19;13:4331-4340. doi: 10.2147/DDDT.S225613. PMID: 31908418; PMCID: PMC6930836.
